A significant milestone in implementing the NMVS (National Medicines Verification System) has been reached: OSMR has passed the 1st assessment organized by EMVO (European Medicines Verification Organization).
In order for the technical on-boarding of a NMVS to begin, EMVO makes sure that all operational and quality assurance goals are met. Therefore, the NMVS IQE (Integrated Qualified Environment), meaning the testing environment, can now be connected to the EMVS (European Medicines Verification System) IQE, allowing for the connectivity between the two systems to be tested from the end-user locations.
OSMR is already preparing the necessary actions so as to successfully pass the 2nd EMVO assessment, enabling thus the implementation of the PILOT phase, estimated for August in the Productive environment (SNVM Prod).
